Frontlight ResearchEarly access
Trial site
Keystone Clinical Studies
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Obesity3 trials
- Type 2 diabetes2 trials
- Frontotemporal dementia1 trial
- Osteoarthritis1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Bristol-Myers Squibb1 trial
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Alzheimer disease1 recruiting
- Osteoarthritis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026